JP2022547324A5 - - Google Patents

Info

Publication number
JP2022547324A5
JP2022547324A5 JP2022516058A JP2022516058A JP2022547324A5 JP 2022547324 A5 JP2022547324 A5 JP 2022547324A5 JP 2022516058 A JP2022516058 A JP 2022516058A JP 2022516058 A JP2022516058 A JP 2022516058A JP 2022547324 A5 JP2022547324 A5 JP 2022547324A5
Authority
JP
Japan
Prior art keywords
composition
use according
alkyl
retinal
hemichannel blocker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022516058A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022547324A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/050579 external-priority patent/WO2021051015A1/en
Publication of JP2022547324A publication Critical patent/JP2022547324A/ja
Publication of JP2022547324A5 publication Critical patent/JP2022547324A5/ja
Priority to JP2025156573A priority Critical patent/JP2025181930A/ja
Pending legal-status Critical Current

Links

JP2022516058A 2019-09-13 2020-09-11 網膜および脈絡膜の構造ならびに機能を回復させるための組成物および方法 Pending JP2022547324A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025156573A JP2025181930A (ja) 2019-09-13 2025-09-19 網膜および脈絡膜の構造ならびに機能を回復させるための組成物および方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962900379P 2019-09-13 2019-09-13
US62/900,379 2019-09-13
US201962903504P 2019-09-20 2019-09-20
US62/903,504 2019-09-20
PCT/US2020/050579 WO2021051015A1 (en) 2019-09-13 2020-09-11 Compositions and methods for rescuing retinal and choroidal structure and function

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025156573A Division JP2025181930A (ja) 2019-09-13 2025-09-19 網膜および脈絡膜の構造ならびに機能を回復させるための組成物および方法

Publications (2)

Publication Number Publication Date
JP2022547324A JP2022547324A (ja) 2022-11-11
JP2022547324A5 true JP2022547324A5 (enExample) 2023-09-20

Family

ID=74866757

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022516058A Pending JP2022547324A (ja) 2019-09-13 2020-09-11 網膜および脈絡膜の構造ならびに機能を回復させるための組成物および方法
JP2025156573A Pending JP2025181930A (ja) 2019-09-13 2025-09-19 網膜および脈絡膜の構造ならびに機能を回復させるための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025156573A Pending JP2025181930A (ja) 2019-09-13 2025-09-19 網膜および脈絡膜の構造ならびに機能を回復させるための組成物および方法

Country Status (6)

Country Link
US (1) US20220401408A1 (enExample)
EP (1) EP4027992A4 (enExample)
JP (2) JP2022547324A (enExample)
CN (2) CN114727981B (enExample)
CA (1) CA3154499A1 (enExample)
WO (1) WO2021051015A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025219925A1 (en) * 2024-04-19 2025-10-23 Auckland Uniservices Limited Compounds for treatment and prevention of diseases, disorders and conditions
WO2025219923A1 (en) * 2024-04-19 2025-10-23 Auckland Uniservices Limited Modulators for treatment and prevention of diseases, disorders and conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130281524A1 (en) * 2008-06-05 2013-10-24 Peter Blower Novel treatments
EP2506847A1 (en) * 2009-12-03 2012-10-10 Proximagen Limited Treatment of infectious diseases
US10465188B2 (en) * 2014-08-22 2019-11-05 Auckland Uniservices Limited Channel modulators
JP6898848B2 (ja) * 2014-09-19 2021-07-07 メモリアル スローン ケタリング キャンサー センター 脳転移を治療するための方法

Similar Documents

Publication Publication Date Title
JP2022547558A5 (enExample)
ES2372929T3 (es) Tratamiento del desgaste muscular con moduladores selectivos del receptor de andrógenos.
JP2022547324A5 (enExample)
JP2023543059A5 (enExample)
ES2324009B1 (es) Composicion farmaceutica de liberacion sostenida de somatostatina o un analogo suyo.
CN110520131A (zh) 缓释可注射的神经类固醇制剂
JP4804431B2 (ja) 長時間作用オキシテトラサイクリン組成物
JP2012519694A5 (enExample)
JP2024542188A5 (enExample)
RS56713B1 (sr) Upotreba malononitrilamida za neuropatski bol
WO2014060472A1 (en) Fatty acid acylated amino acids for oral peptide delivery
JP2023535815A5 (enExample)
WO2009035534A2 (en) Treatment of ischemic eye disease by the systematic pharmaceutical activation of hypoxia inducible factor (hif)
JPH0371413B2 (enExample)
EP4523748A2 (en) Treatment of pain and vasoconstriction
JP2010516702A5 (enExample)
JP2022502432A5 (enExample)
JP2008534453A (ja) 再灌流傷害および再灌流障害の処置のための置換2−チオ−3,5−ジシアノ−4−フェニル−6−アミノピリジンの使用
JPH04290823A (ja) 心臓および血管の肥大および過形成の治療剤
JPWO2019151470A1 (ja) 眼内血管新生及び/又は眼内血管透過性亢進を伴う眼科疾患の予防又は治療のための医薬
JP4261912B2 (ja) 薬剤および薬剤キット
WO2015162195A1 (en) Fatty acid acylated amino acids for oral peptide delivery
WO2020041344A4 (en) Methods and compositions for drugs to treat ophthalmic diseases
JP2022527276A5 (enExample)
JP5674917B2 (ja) テトラチオモリブデン酸の治療的使用